Extracts from the roots of Lindera strychifolia induces apoptosis in lung cancer cells and prolongs survival of tumor-bearing mice

American Journal of Chinese Medicine

Volumn 31, Issue 6, 2003, Pages 857-869

  Li, Yun Mo ^a   Ohno, Yasushi ^a   Minatoguchi, Shinya ^a   Fukuda, Kazunori ^a   Ikoma, Tetsuro ^a   Ohno, Takamasa ^a   Akao, Seigo ^a   Takemura, Genzou ^a   Gotou, Koushi ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticancer Activity; Apoptosis; Lindera strychifolia; Lung Cancer

Indexed keywords

PLANT EXTRACT; CYCLINE; HERBACEOUS AGENT;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CHINESE MEDICINE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LINDERA; LINDERA STRYCHIFOLIA; LUNG CANCER; MOUSE; NONHUMAN; SMALL CELL CARCINOMA; SURVIVAL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER TRANSPLANTATION; CELL STRAIN 3T3; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HUMAN; LEWIS CARCINOMA; LUNG TUMOR; MORTALITY; NICK END LABELING; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PHYTOTHERAPY; SURVIVAL RATE; TUMOR CELL LINE;

3T3-L1 CELLS; ADENOCARCINOMA; ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; CELL SURVIVAL; DRUGS, CHINESE HERBAL; HUMANS; IN SITU NICK-END LABELING; LINDERA; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHYTOTHERAPY; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL RATE;

EID: 2542504579     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X03001545     Document Type: Article

References (29)

1. Barry, M.A., C.A. Behnke and A. Eastman. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40: 2353-2362, 1990.
2. Bertrand, R., E. Solary, J. Jenkins and Y. Pommier. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp. Cell Res. 207: 388-397, 1993.
3. Chen, C.C., Y.L. Huang, J.C. Ou, M.J. Su, S.M. Yu and C.M. Teng. Bioactive principles from the roots of Lindera megaphylla. Planta Med. 57: 406-408, 1991.
4. Corcoran, G.B., L. Fix, D.P. Jones, M.T. Moslen, P. Nicotera, P.A. Oberhammer and R. Buttyan. Apoptosis: molecular control point in toxicity. Toxicol. Appl. Phannacol. 128:169-181, 1994.
5. Evans, D.L. and C. Dive. Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and non-proliferating immature thymocytes. Cancer Res. 53: 2133-2139, 1993.
6. Gavrieli, Y., Y. Sherman and S.A. Ben-Sasson. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501, 1992.
7. Greenlee, R.T., T. Murray, S. Bolden and P.A. Wingo. Cancer statistics, 2000. CA Cancer J. Clin. 50: 7-33, 2000.
8. Hsu, S.M., L. Raine and H. Fanger. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison ABC and unlabeled antibody (PAP) procedure. J. Histochem. Cytochem. 29: 577-580, 1981.
9. Kaufmann, S.H. Induction of endnucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anti-cancer drugs: a cautionary note. Cancer Res. 48: 5870-5878, 1989.
10. Kerr, J.F., A.H. Wyllie and A.R. Currie. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257, 1972.
11. Kondo, Y., Y. Imai, J. Hojo, T. Endo and S. Nozoe. Suppression of tumor cell growth and mitogen response by aporphine alkaloids, dicentrine, glaucine, corydine and apomorphine. J. Pharmacobio. Dyn. 13: 426-431, 1990.
12. Kouno, I., A. Hirai, A. Fukushige, Z.H. Jiang and T. Tanaka. New eudesmane sesquiterpenes from the root of Lindera strychifolia. J. Nat. Prod. 64: 286-288, 2001.
13. Mosmanm, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63, 1983.
14. Onishi, Y., Y. Azuma, Y. Sato, Y. Mizuno, T. Tadakuma and H. Kizaki. Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim. Biophys. Acta 1175: 147-154, 1993.
15. Sarih, M., V. Souvannavong, S.C. Brown and A. Adam. Silica induces apoptosis in macrophages and the release of interleukin-1α and interleukin-1β. J. Leuk. Biol. 54: 407-413, 1993.
16. Searle, J., J.F.R. Kerr and C.J. Bishop. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol. Annu. 17: 229-259, 1982.
17. Sellins, K.S. and J.J. Cohen. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139: 3199-3206, 1987.
18. Smeyne, R.J., M. Vendrell, M. Haward, S.T. Baker, G.G. Miao, K. Schilling, L.M. Robertson, T. Curran and J.I. Morgan. Continuous c-fos expression precedes programmed cell death in vivo. Nature 363: 166-169, 1993.
19. 1-adrenoceptor antagonist, isolated from Lindera megaphylla. Br. J. Phannacol. 104: 651-656, 1991.
20. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
21. Tomita, M., T. Sawada, M. Kozuka, D. Hamano and K. Yoshimura. The alkaloids of Lindera strychnifolia (Sieb, et Zucc.) f. vill. and Lindera umbellate thunb. Yakugaku Zasshi. 89: 737-740, 1969 (Japanese).
22. Wu, Y.C., YF. Liou, S.T. Lu, C.H. Chen, J.J. Chang and K.H. Lee. Cytotoxicity of isoquinoline alkaloids and their N-oxides. Planta Med. 55: 163-165, 1989.
23. Wyllie, A.H., J.F. Kerr and A.R. Currie. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306, 1980.
24. Wyllie, A.M. Apoptosis and carcinogenesis. Eur. J. Cell Biol. 73: 189-197, 1997.
25. Yanagisawa-Shiota, F., H. Sakagami, N. Kuribayashi, M. Lida, T. Sakagami and M. Takeda. Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anti-cancer Res. 15: 259-265, 1995.
26. Yoshida, A., T. Ueda and T. Nakamura. DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells. Jpn. J. Cancer Res. 84: 566-573, 1993.
27. Yu, S.M., C.C. Chen, F.N. Ko, Y.L. Huang, T.F. Huang and C.M. Teng. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. Biochem. Pharmacol. 43: 323-329, 1992a.
28. Yu, S.M., S.Y. Hsu, F.N. Ko, C.C. Chen, Y.L. Huang, T.F. Huang and C.M. Teng. Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br. J. Phannacol. 106: 797-801, 1992b.
29. Yu, S.M., Y.F. Kang, C.C. Chen and C.M. Teng. Effects of dicentrine on haemodynamic, plasma lipid, lipoprotein level and vascular reactivity in hyperlipidaemic rats. Br. J. Pharmacol. 108: 1055-1061, 1993.